Evidence map›Paper›PMID 25800730›Full record

ArticleTrends in microbiology2015

Detecting virulence and drug-resistance mycobacterial phenotypes in vivo.

Graham S Timmins

Abstract read
In one paragraph

Article in Trends in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Graham S TimminsDepartment of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, USA. Electronic address: gtimmins@salud.unm.edu.

Funding

Breath Test for Pseudomonas aeruginosa in CFR21AI081015 · NIAID · UNIVERSITY OF NEW MEXICO · PI TIMMINS, GRAHAM S · 2009 to 2010
$413k
Antimycobacterial NO from KatG Activation of IsoniazidR21AI063486 · NIAID · UNIVERSITY OF NEW MEXICO · PI TIMMINS, GRAHAM S · 2006 to 2007
$370k
NIAID NIH HHS AI063486NIAID NIH HHS AI081015NIAID NIH HHS R21 AI063486NIAID NIH HHS R21 AI081015
6 · The paper itself

Abstract

Bacterial phenotypes are predominantly studied in culture because detection of their specific metabolic pathways in the host is challenging. Development of stable-isotope breath tests, allowing in situ phenotype analyses, may endow diagnostics with new modalities based upon direct monitoring of in vivo microbial metabolism and host-pathogen phenotypic interactions.

Indexed as

Drug Resistance, BacterialAnimalsAntitubercular AgentsBreath TestsHost-Pathogen InteractionsHumansLungMetabolic Networks and PathwaysMycobacterium tuberculosisPhenotypeVirulenceAntitubercular Agentsbacteriabreath testdiagnosismetabolismphenotype

Identifiers

PMID25800730
PMCPMC4458167

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.